ISTH guidelines for VITT laboratory diagnosis in patients presenting with clinical (thrombosis) and biological hemostasis abnormalities (thrombocytopenia) after vaccination recommend anti-PF4 testing using enzyme-linked immunosorbent assay (ELISA) followed by a functional platelet activation test in case of positive ELISA result [15]. This evidence concerns the gene PF4 and deep vein thrombosis.